Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Merion

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Transplantation|September 1, 1989
The hepatic artery in liver transplantationR M Merion, G D Burtch, J M Ham, et al.
Transplantation|August 1, 1990
A prospective controlled trial of cold-storage versus machine-perfusion preservation in cadaveric renal transplantationR M Merion, H K Oh, F K Port, et al.
Transplantation Proceedings|October 1, 1988
Procurement of kidneys with anomalies: long-term outcomeL Rosenberg, K Granke, D A Campbell, et al.
Transplantation Proceedings|February 11, 1991
Hepatic preservation with University of Wisconsin solution is associated with reduced allograft rejectionD A Campbell, R M Merion, J M Ham, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 3, 2011
Impact of MELD-based allocation on end-stage renal disease after liver transplantationP Sharma, D E Schaubel, M K Guidinger, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 24, 2009
Stimulus for organ donation: a survey of the American Society of Transplant Surgeons membershipJ R Rodrigue, K Crist, J P Roberts, et al.
Lancet (London, England)|January 6, 1990
Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIAM R Lucey, J C Kolars, R M Merion, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 28, 2010
Donation after cardiac death liver transplantation: predictors of outcomeA K Mathur, J Heimbach, D E Steffick, et al.
Transplantation Proceedings|June 1, 1988
Predictors of outcome in cyclosporine-treated recipients of second renal transplantsR M Merion, D A Campbell, D C Dafoe, et al.
Transplantation Proceedings|February 1, 1989
Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantationZ J Nestor, L L Rocher, R M Merion, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Transplantation|September 1, 1989
The hepatic artery in liver transplantationR M Merion, G D Burtch, J M Ham, et al.
Transplantation|August 1, 1990
A prospective controlled trial of cold-storage versus machine-perfusion preservation in cadaveric renal transplantationR M Merion, H K Oh, F K Port, et al.
Transplantation Proceedings|October 1, 1988
Procurement of kidneys with anomalies: long-term outcomeL Rosenberg, K Granke, D A Campbell, et al.
Transplantation Proceedings|February 11, 1991
Hepatic preservation with University of Wisconsin solution is associated with reduced allograft rejectionD A Campbell, R M Merion, J M Ham, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 3, 2011
Impact of MELD-based allocation on end-stage renal disease after liver transplantationP Sharma, D E Schaubel, M K Guidinger, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 24, 2009
Stimulus for organ donation: a survey of the American Society of Transplant Surgeons membershipJ R Rodrigue, K Crist, J P Roberts, et al.
Lancet (London, England)|January 6, 1990
Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIAM R Lucey, J C Kolars, R M Merion, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 28, 2010
Donation after cardiac death liver transplantation: predictors of outcomeA K Mathur, J Heimbach, D E Steffick, et al.
Transplantation Proceedings|June 1, 1988
Predictors of outcome in cyclosporine-treated recipients of second renal transplantsR M Merion, D A Campbell, D C Dafoe, et al.
Transplantation Proceedings|February 1, 1989
Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantationZ J Nestor, L L Rocher, R M Merion, et al.
Pageof 14